Trial Profile
Phase II Study of RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2014
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 03 Nov 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Jun 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.